The New York Entrepreneur

Novo Nordisk CEO to testify at Senate hearing over high weight loss drug prices

Read Time:7 Second

Sen. Bernie Sanders argues that Novo Nordisk charges Americans substantially higher prices for its drugs than it does for patients in other countries.

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %

Average Rating

5 Star
0%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%

Leave a Reply

Your email address will not be published. Required fields are marked *

Previous post Legal & General hires PGIM exec to lead £1.1 trillion asset management business
Next post AutoZone’s stock drops after a rare profit miss, as U.S. sales come up short